₁₆Charles N Bernstein

Summary for 2004 [at-glance overview of Charles N Bernstein work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Charles N Bernstein. According to available data, in 2004 Charles N Bernstein published at least 16 articles. This work was completed in collaboration with several authors including Rawsthorne, Patricia and Fedorak, Richard N. Many other authors have collaborated with Charles N Bernstein as well. There is no information about the funding or the grants awarded to support this work.

Charles N Bernstein is a key opinion leader on Inflammatory Bowel Diseases, Colitis, Ulcerative. This author's highest rank is 1 when compared to all other authors using the keyword Inflammatory Bowel Diseases. Analysis of the article abstracts and the titles suggests that Charles N Bernstein professional interests are focused around "inflammatory bowel disease", "disease ulcerative colitis" and "crohn disease ulcerative". These might also be referred to as "crohn disease", "inflammatory bowel" or "ulcerative colitis". Statistical analysis shows that Charles N Bernstein's writing is likely to contains terms "disease", "patients", "crohn", "bowel", "inflammatory" and "colitis".

Unfortunately, there is not enough information to establish Charles N Bernstein affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Charles N Bernstein]

Do you know Charles N Bernstein who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Charles N Bernstein]

₃₃Bernstein, C N

Year 2004 Charts [Charles N Bernstein frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Charles N Bernstein publication and funding history for the range of years]

Emails (3) [email addresses extracted from Charles N Bernstein affiliations]

hidden to prevent spam, click here to reveal

Charles N Bernstein Coauthors (39) [all coauthors with the number of joint publications]

explore visually

3

₃Rawsthorne, Patricia

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

₆van Deventer, Sander J

1

₅Rachmilewitz, Daniel

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (14) [condensed summary of the Charles N Bernstein affiliations, the leading number and the color conveys importance]

₂Section of Gastroenterology, University of Manitoba, Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Manitoba, Canada.
₂Section of Gastroenterology, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
₁Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, 804F-715 McDermot Avenue, Winnipeg, Manitoba R3E 3P4, Canada.
₁University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, 804F-715 McDermot Avenue, Winnipeg, Manitoba, Canada R3E 3P4.
₁University of Manitoba, 804F-715 McDermot Avenue, Winnipeg, Manitoba, Canada.
₁University of Calgary, Calgary, Canada.
₁Health Statistics Division, Statistics Canada, Ottawa, Ontario.
₁Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.
₁Alimentary Pharmabiotic Centre and Department of Medicine, National University of Ireland. Cork.
₁Department of Internal Medicine, and University of Manitoba Inflammatory Bowel Disease Clinical and Research Center, Winnipeg, Manitoba, Canada.
₁University of Manitoba Department of Internal Medicine, Winnipeg, MB, Canada.
₁Department of Pharmacology and Therapeutics, University of Manitoba, Division of Neuroscience, St. Boniface Hospital Research Centre, Winnipeg, Canada.
₁Inflammatory Bowel Disease Clinical and Research Centre, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
₁Gastrointestinal Unit, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.

Key Opinion Leader In [Charles N Bernstein is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁Inflammatory Bowel Diseases | ₄Colitis, Ulcerative | ₆Crohn Disease | ₉₁Canada | ₃₁₆Risk Assessment | ₃₆₉Adolescent | ₈₁₃Adult

Keywords (32) [keywords assigned to Charles N Bernstein articles by PubMed, the leading number and the color conveys importance]

₁₆Humans | ₁₀Adult | ₉Female | ₉Male | ₈Crohn Disease | ₇Inflammatory Bowel Diseases | ₇Middle Aged | ₆Adolescent | ₆Colitis, Ulcerative | ₅Aged | ₄Treatment Outcome | ₃Child | ₃Canada | ₃Risk Assessment | ₂Databases, Factual | ₂Hospitalization | ₂Gastrointestinal Agents | ₂Health Care Surveys | ₂Animals | ₂Child, Preschool | ₂Time Factors | ₂Colonic Neoplasms | ₂Colonoscopy | ₂Complementary Therapies | ₂Infant | ₂Incidence | ₂Recurrence | ₂Risk Factors | ₂Antibodies, Monoclonal | ₂Predictive Value of Tests | ₁Length of Stay | ₁Drug Utilization

Charles N Bernstein Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Charles N Bernstein might be a good expert witness on these terms]

₃₅disease | ₂₆patients | ₂₁crohn | ₁₆bowel | ₁₃inflammatory | ₁₂colitis | ₁₂pylori | ₁₂ulcerative | ₁₂cyfip2 | ₁₂paratuberculosis | ₁₁rectal | ₁₁cells | ₁₀ibd | ₁₀levels | ₉uc | ₉cd | ₉children | ₈controls | ₈adhesion | ₈rate | ₈study | ₇increased | ₇biopsy | ₇cd4 | ₆infliximab | ₆cases | ₆siblings | ₆sparing | ₆therapy | ₆infected | ₅ms | ₅population-based
₂₀crohn disease | ₁₃inflammatory bowel | ₁₁ulcerative colitis | ₁₀bowel disease | ₆rectal sparing | ₆cd4 cells | ₆disease ulcerative | ₄healthy controls | ₄ms patients | ₄stool antigen | ₄helicobacter pylori | ₄health care | ₄canadian nations | ₄nations community | ₄biopsy specimens | ₃cells ms | ₃infliximab maintenance | ₃cyfip2 protein | ₃pylori acquisition | ₃cell adhesion | ₃cases rectal | ₃proximal biopsy | ₃population-based case | ₃small bowel | ₃patients inflammatory | ₃rectal proximal | ₃patients healthy | ₃chronicity activity | ₃fibronectin-mediated adhesion | ₃mycobacterium paratuberculosis | ₃medicine use | ₃case control
₁₀inflammatory bowel disease | ₆disease ulcerative colitis | ₆crohn disease ulcerative | ₄canadian nations community | ₃fistulizing crohn disease | ₃case control study | ₃patients inflammatory bowel | ₃patients healthy controls | ₃rectal proximal biopsy | ₃population-based case control | ₃pylori stool antigen | ₂patients crohn disease | ₂uc patients healthy | ₂bowel disease ibd | ₂colitis retrospective study | ₂maintenance therapy fistulizing | ₂presentation ulcerative colitis | ₂controls nonaffected siblings | ₂paratuberculosis patients crohn | ₂small bowel transplant | ₂pylori acquisition children | ₂therapy fistulizing crohn | ₂control study seroprevalence | ₂health care resources | ₂stool antigen testing | ₂cd4 cells ms | ₂individuals inflammatory bowel | ₂paratuberculosis seropositivity rate | ₂resources individuals inflammatory | ₂study newly diagnosed | ₂colonic involvement initial | ₂stool antigen status

Reader's Comments (0) [comments posted by readers of Charles N Bernstein profile]